Right Turn: Commercializing Living Therapies podcast

In 2016 I shared a list of podcasts that I thought Signals’ readers might enjoy. I think it’s definitely time to update that list, and I’m excited to tell you about a new podcast that’s about to launch: Commercializing Living Therapies with CCRM.

Commercializing Living Therapies with CCRM will feature cell and gene therapy industry experts and influencers sharing insider insights, information and trend forecasts. Unlike some of CCRM’s other educational media that are developed for a variety of audiences – such as Signals and CCRM Goes Live – CCRM’s podcast is meant to educate, intrigue and inspire professionals working in industry. So, while anyone can listen, we are assuming that our audience works in the field of cell and gene therapies or has an interest in how it operates.

Our launch date, while imminent, hasn’t been set, but I can share that our first episode will feature Drs. Janet Rossant and Phil Vanek speaking broadly about the industry, the importance of building awareness of living therapies and the need to commercialize them. Episode two will feature Dr. Cynthia Lavoie and Geoff MacKay providing insight on investing in regenerative medicine companies and helping them through the infamous “valley of death,” something they both have decades of experience with. Future topics will include manufacturing and supply chain, synthetic biology, gene editing, and reimbursement, with more to come.

Once it’s live, you’ll be able to listen to and follow Commercializing Living Therapies with CCRM in your favourite streaming app: Apple Podcasts, Spotify, Amazon Music, Stitcher, Google Podcasts, iHeartRadio, Pocket Casts or RSS, and you’ll also be able to find episodes on CCRM’s website. You can also subscribe to CCRM’s newsletter to make sure you don’t miss the first episode.

Regenerative medicine podcasts

Since I last blogged about podcasts, many new ones have launched. This is not an exhaustive list of those in the regenerative medicine field, so be sure to add your favourite(s) in the comments section below.

• The Stem Cell Report with Martin Pera by ISSCR: https://www.buzzsprout.com/1661578
• Cell & Gene: The Podcast by Cell & Gene: https://www.cellandgene.com/solution/cell-gene-the-podcast
• The Stem Cell Podcast by STEMCELL Technologies: https://stemcellpodcast.com
• Stem Cells @Lunch Digested by King’s College London Centre for Stem Cells & Regenerative Medicine: https://soundcloud.com/user-563815853
• This Week in Stem Cells with Dr. Paul Knoepfler by The Niche: https://ipscell.com/this-week-in-stem-cells-with-dr-knoepfler-podcast/
• The Stem Cell Channel by UC San Diego: https://american-podcasts.com/podcast/stem-cell-channel-audio

For something completely different, listen to the Bad Batch podcast by Wondery, featuring Laura Bell, the award-winning host and reporter of Dr. Death. Bad Batch explores greed and desperation in the multibillion-dollar stem cell industry.

The following two tabs change content below.

• Bio
• Latest Posts

Stacey Johnson

Stacey Johnson is the editor of Signals and a contributor. For 25 years, Stacey has been providing strategic communications counsel to government, corporate, technology and health organizations. She began her career at the CTV Television Network and then moved to Hill & Knowlton Canada where she advised clients in a variety of industries and sectors. Stacey is the Vice President, Communications and Marketing for CCRM, a leader in developing and commercializing regenerative medicine-based technologies and cell and gene therapies. She has a Master's degree in Public Relations. You can follow her on Twitter @msstaceyerin.

Latest posts by Stacey Johnson (see all)

• Right Turn: #pinksocks, diabetes news and other ramblings - June 24, 2025
• Right Turn: Some takeaways from Advanced Therapies Week 2025 - January 31, 2025
• Right Turn: The top 10 most-read blog posts in 2024 - January 2, 2025